kadcyla

Generic: ado-trastuzumab emtansine

Labeler: genentech, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name kadcyla
Generic Name ado-trastuzumab emtansine
Labeler genentech, inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

trastuzumab emtansine 20 mg/mL

Manufacturer
Genentech, Inc.

Identifiers & Regulatory

Product NDC 50242-088
Product ID 50242-088_b5871dd4-8ade-461c-a4f2-7c71c2fc8393
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125427
Listing Expiration 2026-12-31
Marketing Start 2013-02-22

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50242088
Hyphenated Format 50242-088

Supplemental Identifiers

RxCUI
1658084 1658087 1658089 1658091
UNII
SE2KH7T06F

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name kadcyla (source: ndc)
Generic Name ado-trastuzumab emtansine (source: ndc)
Application Number BLA125427 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (50242-088-01) / 5 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (1)

Ingredients (1)

trastuzumab emtansine (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "b5871dd4-8ade-461c-a4f2-7c71c2fc8393", "openfda": {"unii": ["SE2KH7T06F"], "rxcui": ["1658084", "1658087", "1658089", "1658091"], "spl_set_id": ["23f3c1f4-0fc8-4804-a9e3-04cf25dd302e"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (50242-088-01)  / 5 mL in 1 VIAL, SINGLE-USE", "package_ndc": "50242-088-01", "marketing_start_date": "20130222"}], "brand_name": "KADCYLA", "product_id": "50242-088_b5871dd4-8ade-461c-a4f2-7c71c2fc8393", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "50242-088", "generic_name": "ADO-TRASTUZUMAB EMTANSINE", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "KADCYLA", "active_ingredients": [{"name": "TRASTUZUMAB EMTANSINE", "strength": "20 mg/mL"}], "application_number": "BLA125427", "marketing_category": "BLA", "marketing_start_date": "20130222", "listing_expiration_date": "20261231"}